Loading
Latest filing published 19 Nov 2021 for Trillium Therapeutics Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Rosemary Harrison has a single filing on record, published on 19 November 2021: a transaction in Trillium Therapeutics Inc. One trade is not enough to describe a pattern. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration